<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34978525</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-690X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Prion</Title>
          <ISOAbbreviation>Prion</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The first non-prion pathogen identified: neurotropic influenza virus.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>6</EndPage>
          <MedlinePgn>1-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19336896.2021.2015224</ELocationID>
        <Abstract>
          <AbstractText>The cellular isoform of prion protein, designated PrP<sup>C</sup>, is a membrane glycoprotein expressed most abundantly in the brain, particularly by neurons, and its conformational conversion into the abnormally folded, amyloidogenic isoform, PrP<sup>Sc</sup>, is an underlying mechanism in the pathogenesis of prion diseases, a group of neurodegenerative disorders in humans and animals. Most cases of these diseases are sporadic and their aetiologies are unknown. We recently found that a neurotropic strain of influenza A virus (IAV/WSN) caused the conversion of PrP<sup>C</sup> into PrP<sup>Sc</sup> and the subsequent formation of infectious prions in mouse neuroblastoma cells after infection. These results show that IAV/WSN is the first non-prion pathogen capable of inducing the conversion of PrP<sup>C</sup> into PrP<sup>Sc</sup> and propagating infectious prions in cultured neuronal cells, and also provide the intriguing possibility that IAV infection in neurons might be a cause of or be associated with sporadic prion diseases. Here, we present our findings of the IAV/WSN-induced conversion of PrP<sup>C</sup> into PrP<sup>Sc</sup> and subsequent propagation of infectious prions, and also discuss the biological significance of the conversion of PrP<sup>C</sup> into PrP<sup>Sc</sup> in virus infections.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sakaguchi</LastName>
            <ForeName>Suehiro</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Neurobiology, The Institute for Enzyme Research (KOSOKEN), Tokushima University, Tokushima 770-8503, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hara</LastName>
            <ForeName>Hideyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Molecular Neurobiology, The Institute for Enzyme Research (KOSOKEN), Tokushima University, Tokushima 770-8503, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Prion</MedlineTA>
        <NlmUniqueID>101472305</NlmUniqueID>
        <ISSNLinking>1933-6896</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018621">PrPC Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000072002">Prion Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011328">Prions</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009975" MajorTopicYN="Y">Orthomyxoviridae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018621" MajorTopicYN="Y">PrPC Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017096" MajorTopicYN="Y">Prion Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072002" MajorTopicYN="N">Prion Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011328" MajorTopicYN="Y">Prions</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Prion</Keyword>
        <Keyword MajorTopicYN="Y">conformational conversion</Keyword>
        <Keyword MajorTopicYN="Y">influenza virus</Keyword>
        <Keyword MajorTopicYN="Y">neurodegenerative disease</Keyword>
        <Keyword MajorTopicYN="Y">prion disease</Keyword>
        <Keyword MajorTopicYN="Y">prion protein</Keyword>
        <Keyword MajorTopicYN="Y">protein polymerization</Keyword>
        <Keyword MajorTopicYN="Y">virus infection</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>3</Day>
          <Hour>12</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34978525</ArticleId>
        <ArticleId IdType="pmc">PMC8741280</ArticleId>
        <ArticleId IdType="doi">10.1080/19336896.2021.2015224</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Prusiner SB.
Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–13383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC33918</ArticleId>
            <ArticleId IdType="pubmed">9811807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases. Am J Pathol. 1995;146(4):785–811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1869256</ArticleId>
            <ArticleId IdType="pubmed">7717447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheckel C, Aguzzi A. Prions, prionoids and protein misfolding disorders. Nat Rev Genet. 2018;19(7):405–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29713012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 1993;90(23):10962–10966.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC47901</ArticleId>
            <ArticleId IdType="pubmed">7902575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oesch B, Westaway D, Walchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985;40(4):735–746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2859120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prusiner SB. Molecular biology of prion diseases. Science. 1991;252(5012):1515–1522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1675487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hackl S, Becker CFW. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications. J Pept Sci. 2019;25(10):e3216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6899880</ArticleId>
            <ArticleId IdType="pubmed">31713950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prusiner SB. Biology of prion diseases. J Acquir Immune Defic Syndr. 1993;6(6):663–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8496798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandel JP, Peckeu L, Haik S. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol. 2013;20(4):395–397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23587616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heinemann U, Krasnianski A, Meer B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(5):1350–1359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17472986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maddox RA, Person MK, Blevins JE, et al. Prion disease incidence in the United States: 2003-2015. Neurology. 2020;94(2):e153–e7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31757870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webb TE, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131(10):2632–2646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2570713</ArticleId>
            <ArticleId IdType="pubmed">18757886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cracco L, Appleby BS, Gambetti P. Fatal familial insomnia and sporadic fatal insomnia. Handb Clin Neurol. 2018;153:271–299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29887141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921–925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8598754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66(1):255–265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14522863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jarrett JT, Lansbury PT Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?
Cell. 1993;73(6):1055–1058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8513491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature. 1994;370(6489):471–474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7913989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marttila RJ, Rinne UK, Halonen P, et al. Herpesviruses and parkinsonism. Herpes simplex virus types 1 and 2, and cytomegalovirus antibodies in serum and CSF. Arch Neurol. 1981;38(1):19–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6257211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vlajinac H, Dzoljic E, Maksimovic J, et al. Infections as a risk factor for Parkinson’s disease: a case-control study. Int J Neurosci. 2013;123(5):329–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23270425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009;106(33):14063–14068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2729020</ArticleId>
            <ArticleId IdType="pubmed">19667183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamieson GA, Maitland NJ, Wilcock GK, et al. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J Med Virol. 1991;33(4):224–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1649907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Readhead B, Haure-Mirande J-V, Funk CC, et al. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018;99(1):64–82 e7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6551233</ArticleId>
            <ArticleId IdType="pubmed">29937276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S, Hossinger A, Heumuller SE, et al. Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nat Commun. 2021;12(1):5739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8526834</ArticleId>
            <ArticleId IdType="pubmed">34667166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hara H, Chida J, Uchiyama K, et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep. 2021;11(1):10109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8115602</ArticleId>
            <ArticleId IdType="pubmed">33980968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler DA, Scott MR, Bockman JM, et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol. 1988;62(5):1558–1564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC253182</ArticleId>
            <ArticleId IdType="pubmed">3282080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishida N, Harris DA, Vilette D, et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol. 2000;74(1):320–325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC111542</ArticleId>
            <ArticleId IdType="pubmed">10590120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita K, Yamaguchi Y, Mori T, et al. Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions. Cell Mol Neurobiol. 2011;31(7):999–1008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21516351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferhadian D, Contrant M, Printz-Schweigert A, et al. Structural and Functional Motifs in Influenza Virus RNAs. Front Microbiol. 2018;9:559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5884886</ArticleId>
            <ArticleId IdType="pubmed">29651275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adler V, Zeiler B, Kryukov V, et al. Small, highly structured RNAs participate in the conversion of human recombinant PrPSen to PrPRes in vitro. J Mol Biol. 2003;332(1):47–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12946346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, Yang F, Hu Y, et al. Lipid Interaction Converts Prion Protein to a PrPSc-like Proteinase K-Resistant Conformation under Physiological Conditions. Biochemistry. 2007;46(23):7045–7053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17503780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, Wang X, Yuan CG, et al. Generating a prion with bacterially expressed recombinant prion protein. Science. 2010;327(5969):1132–1135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2893558</ArticleId>
            <ArticleId IdType="pubmed">20110469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature. 2003;425(6959):717–720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14562104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetz G, Tetz V. Prion-like Domains in Eukaryotic Viruses. Sci Rep. 2018;8(1):8931.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5997743</ArticleId>
            <ArticleId IdType="pubmed">29895872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haviv Y, Avrahami D, Ovadia H, et al. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch Neurol. 2008;65(6):762–775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18541796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leblanc P, Alais S, Porto-Carreiro I, et al. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. Embo J. 2006;25 (12):2674–2685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1500854</ArticleId>
            <ArticleId IdType="pubmed">16724107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehresmann DW, Hogan RN. Acceleration of scrapie disease in mice by an adenovirus. Intervirology. 1986;25(2):103–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3013796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanton JB, Knowles DP, O’Rourke KI, et al. Small-Ruminant Lentivirus Enhances PrPSc Accumulation in Cultured Sheep Microglial Cells. J Virol. 2008;82(20):9839–9847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2566263</ArticleId>
            <ArticleId IdType="pubmed">18684809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lins N, Mourao L, Trevia N, et al. Virus Infections on Prion Diseased Mice Exacerbate Inflammatory Microglial Response. Oxid Med Cell Longev. 2016;2016:3974648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5149707</ArticleId>
            <ArticleId IdType="pubmed">28003864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wickner RB, Masison DC, Edskes HK. [PSI] and [URE3] as yeast prions. Yeast. 1995;11(16):1671–1685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8720070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>True HL, Berlin I, Lindquist SL. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature. 2004;431(7005):184–187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15311209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature. 2000;407(6803):477–483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11028992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki G, Shimazu N, Tanaka M. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science. 2012;336(6079):355–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22517861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruland J. Inflammasome: putting the pieces together. Cell. 2014;156(6):1127–1129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24630715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, et al. Alzheimer’s Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron. 2018;99(1):56–63 e3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6075814</ArticleId>
            <ArticleId IdType="pubmed">30001512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chida J, Hara H, Yano M, et al. Prion protein protects mice from lethal infection with influenza A viruses. PLoS Pathog. 2018;14:e1007049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5953499</ArticleId>
            <ArticleId IdType="pubmed">29723291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d’Errico P, Meyer-Luehmann M. Mechanisms of Pathogenic Tau and Abeta Protein Spreading in Alzheimer’s Disease. Front Aging Neurosci. 2020;12:265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7481386</ArticleId>
            <ArticleId IdType="pubmed">33061903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Billings LM, Oddo S, Green KN, et al. Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45(5):675–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15748844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis. 2008;5(3–4):118–121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18322367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duda JE, Lee VM, Trojanowski JQ. Neuropathology of synuclein aggregates. J Neurosci Res. 2000;61(2):121–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10878583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marreiros R, Muller-Schiffmann A, Trossbach SV, et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation. Proc Natl Acad Sci U S A. 2020;117(12):6741–6751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7104400</ArticleId>
            <ArticleId IdType="pubmed">32152117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wozniak MA, Itzhaki RF, Shipley SJ, et al. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429(2–3):95–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17980964</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
